Comment by olliepro

Much of the scientific medical literature is behind paywalls. They have tapped into that datasource (whereas ChatGPT doesn't have access to that data). I suspect that were the medical journals to make a deal with OpenAI to open up the access to their articles/data etc, that open evidence would rely on the existing customers and stickiness of the product, but in that circumstance, they'd be pretty screwed.

For example, only 7% of pharmaceutical research is publicly accessible without paying. See https://pmc.ncbi.nlm.nih.gov/articles/PMC7048123/